ETFIQData as of Nov 18, 2026. · etfiq.com/funds/fxh

FXH Fact Sheet: First Trust Health Care AlphaDEX Fund

Share
$133.43
close, Nov 18, 2026

Over the year to Nov 18, 2026, FXH returned +20.0% in total and charged 0.61% a year.

1-year total return
+20.0%
to Nov 18, 2026
Expense ratio
0.61%
a year
Net assets
$1.2bn
on Nov 17, 2026
Net flow, last 5 trading days
+$6.7m
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

FXH $12,000 +20.0% · IWB $11,170 +11.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+0.8%
3 months−0.9%
Year to date+17.8%
1 year+20.0%
3 years+43.4%
5 years+12.5%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Centene Corporation2.69%
Zimmer Biomet Holdings, Inc.2.65%
Universal Health Services, Inc. (Class B)2.54%
The Cigna Group2.50%
Medpace Holdings, Inc.2.41%
Regeneron Pharmaceuticals, Inc.2.33%
GE HealthCare Technologies Inc.2.31%
Eli Lilly and Company2.26%
Solventum Corporation2.25%
Zoetis Inc.2.21%

FXH top ten by weight, 24.1% of the fund, of its 72 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the StrataQuant Health Care Index · First traded May 10, 2007 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, FXH Fact Sheet: First Trust Health Care AlphaDEX Fund. Data as of Nov 18, 2026. https://etfiq.com/funds/fxh/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/fxh.